Manufacturing

Articles

GE Healthcare Life Sciences’ new facility for cell and gene processing supplies will be open in 2022. 

GE Builds Single-Use Kit Manufacturing Facility in Switzerland

Agnes Shanley is senior editor of Pharmaceutical Technology.

Aiming to break the bottlenecks that are slowing commercialization of innovative therapies, a new $50-million center in Boston will develop both cell and viral vector products within a single facility.


New Center Marks Aggressive Push into CGMP Manufacturing of Cell and Gene Therapies

Gary Dailey is vice-president, Global Marketing, Electronic Materials, at Avantor.

Claudia BerrÃ³n is senior vice-president, Strategy and Commercial Operations, Biopharma Production at Avantor.

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.

Applying Lessons Learned from the Semiconductor Industry

Communications and planning are crucial to recovering from supply, operations, and facility disruptions. 

Mitigating Risk to Secure the Drug Supply Chain

The collaboration aims to reduce “vein-to-vein” time for patients and to optimize manufacturing and supply operations.

Adaptimmune, Cryoport in Three-Year Cell Therapy Supply Chain Pact

The partnership combines global CDMO services with a cellular orchestration platform.

TrakCel Forms Cell and Gene Therapy Supply Partnership with WuXi AppTec

Spectrum Laboratory Products received an FDA warning letter after violations were found at its New Brunswick, NJ facility.

New Jersey Facility Receives FDA Warning Letter

The acquisition strengthens BioLife’s position as a supplier of disruptive, enabling solutions used for manufacturing, storage, and distribution of cell and gene therapies.

BioLife Solutions Completes Acquisition of SAVSU Technologies

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Machine vision systems have been an integral part of pharma manufacturing and packaging for many years and, with the introduction of stricter safety regulations, are set to become more vital.


Farther Than the Eye Can See

As patient-centered therapies and clinical trials become more important, innovation is providing more control and transparency in the way that pharmaceuticals are delivered. 